Suppr超能文献

特定外科手术及平台的成本、有效性和成本效益

Costs, Effectiveness, and Cost-Effectiveness of Selected Surgical Procedures and Platforms

作者信息

Prinja Shankar, Nandi Arindam, Horton Susan, Levin Carol, Laxminarayan Ramanan

Abstract

This volume has shown that universal provision of a package of essential surgical services would avert an estimated 1.5 million deaths per year, or 6–7 percent of all avertable deaths in LMICs (Debas and others 2006; Mock and others 2015). Although approximately 234 million surgeries are performed worldwide each year, the distribution is very inequitable (Funk and others 2010). Nearly two billion people live in areas with a density of less than one operating room per 100,000 population (Funk and others 2010); in high-income countries (HICs), the density is 14 per 100,000. With this scarcity of surgical services in low- and middle-income countries (LMICs), the need for scaling up is imperative. Challenges to the implementation of surgical services in resource-limited environments are substantial and include limited human resources, transportation systems, and access to electricity and water (Hsia and others 2012; Kruk and others 2010). Moreover, evidence on the different attributes of scaling up is insufficient. Scaling up requires increasing the share of current income devoted to spending on health, as well as major investments in facilities and human resources. Priority interventions in LMICs are those that are cost-effective and reasonable in cost; is defined relative to the prevalence of the condition and size of the government health budget. Feasibility is important, particularly in low-income countries (LICs), which lack many health systems resources. Some deficiencies can be remedied if cost and cost-effectiveness considerations identify additional investments that provide good value. For example, purchasing more radiotherapy equipment or training additional personnel may make a substantial difference. Other deficiencies are harder to remedy. LMICs typically have limited ability to manage resources, which restricts how referral or organized screening systems work. In this chapter, we discuss evidence showing that some types of surgery can be both highly cost-effective—saving lives or improving the quality of life—and affordable. We focus on a set of surgical interventions that can be undertaken at first-level hospitals, or in some cases, in clinics or mobile facilities. These interventions include selected emergency surgeries, surgeries associated with reproductive functions, and nonemergency surgeries. We do not cover other types of surgery that also may be cost-effective and even modest in cost but that are more suited to referral hospitals in LMICs, namely, surgery for cardiovascular disease, cancer, organ transplantation, and neurosurgery. Surgical interventions for cardiovascular disease, such as left main coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty, have been very cost-effective in certain population groups in HICs, compared with medical management (Tengs and others 1995); this outcome is likely to apply to some population groups in LMICs. Basic surgical interventions for cancer treatment are likely to be cost-effective and, in some cases, feasible at the first-level hospital, for example, oophorectomy, simple hysterectomy, radical mastectomy, and colectomy. Very few cost-effectiveness results are available on these interventions, surveyed in Horton and Gauvreau (2015) and not discussed further here. Kidney transplants, although relatively costly, may be cost-effective (Tengs and others 1995). We do not cover neurosurgery, such as surgery to treat epilepsy or to treat infant hydrocephalus, although Warf and others (2011) show that such surgeries can be cost-effective in Sub-Saharan Africa. Cost-effectiveness of reproductive surgery is considered in volume 2, (Black and others forthcoming). Dental surgery is not covered because of a lack of studies using quality-adjusted life year (QALY), disability-adjusted life year (DALY), life year saved (LYS), and death-averted outcome measures. The set of conditions covered in the chapter is listed in annex 18A and includes interventions discussed in other chapters in this volume; chapter 1 provides a more comprehensive list of the detailed procedures considered. These are surgery types that can feasibly be undertaken at first-level hospitals, although they may also be undertaken at second-level hospitals, often when urgent cases arrive at these emergency units. Some can be undertaken in specialized facilities, for example, a cataract hospital, a specialized mobile facility, a short-term surgical mission focused on specific surgical conditions, or a trauma center. We briefly summarize the literature on the cost-effectiveness of different ways of organizing facilities for surgery. Equity and affordability are important considerations when prioritizing care. We review both of these issues before discussing data limitations and presenting conclusions. This chapter uses World Health Organization (WHO) geographical regions: Africa, the Americas, South-East Asia, Europe, Eastern Mediterranean, and Western Pacific.

摘要

本卷内容表明,普遍提供一套基本外科服务每年可避免约150万人死亡,占低收入和中等收入国家(LMICs)所有可避免死亡人数的6% - 7%(德巴斯等人,2006年;莫克等人,2015年)。尽管全球每年进行约2.34亿例手术,但分布极不均衡(芬克等人,2010年)。近20亿人生活在手术室密度低于每10万人口1间的地区(芬克等人,2010年);在高收入国家(HICs),这一密度为每10万人口14间。鉴于低收入和中等收入国家外科服务如此匮乏,扩大服务规模势在必行。在资源有限的环境中实施外科服务面临诸多挑战,包括人力资源、运输系统以及电力和水供应有限(夏等人,2012年;克鲁克等人,2010年)。此外,关于扩大规模的不同属性的证据不足。扩大规模需要增加当前用于卫生支出的收入份额,以及对设施和人力资源的重大投资。低收入和中等收入国家的优先干预措施是那些具有成本效益且成本合理的措施;成本效益是相对于疾病流行率和政府卫生预算规模来定义的。可行性很重要,特别是在缺乏许多卫生系统资源的低收入国家(LICs)。如果成本和成本效益考量确定了能提供高价值的额外投资,一些不足是可以弥补的。例如,购买更多放疗设备或培训更多人员可能会产生重大影响。其他不足则更难弥补。低收入和中等收入国家通常管理资源的能力有限,这限制了转诊或有组织的筛查系统的运作方式。在本章中,我们讨论的证据表明,某些类型的手术既具有很高的成本效益——挽救生命或改善生活质量,又具有可承受性。我们关注一组可在一级医院进行的外科干预措施,在某些情况下,也可在诊所或移动设施中进行。这些干预措施包括特定的急诊手术、与生殖功能相关的手术以及非急诊手术。我们不涉及其他类型的手术,尽管这些手术也可能具有成本效益且成本适中,但更适合低收入和中等收入国家的转诊医院,即心血管疾病、癌症、器官移植和神经外科手术。与药物治疗相比,心血管疾病的外科干预措施,如左主干冠状动脉搭桥手术和经皮冠状动脉腔内血管成形术,在高收入国家的某些人群中具有很高的成本效益(滕斯等人,1995年);这一结果可能也适用于低收入和中等收入国家的某些人群。癌症治疗的基本外科干预措施可能具有成本效益,在某些情况下,在一级医院也是可行的,例如卵巢切除术、单纯子宫切除术、根治性乳房切除术和结肠切除术。关于这些干预措施的成本效益结果很少,在霍顿和高夫罗(2015年)中有相关调查,在此不再进一步讨论。肾移植虽然成本相对较高,但可能具有成本效益(滕斯等人,1995年)我们不涉及神经外科手术,如治疗癫痫或婴儿脑积水的手术,尽管沃夫等人(2011年)表明此类手术在撒哈拉以南非洲可能具有成本效益。生殖手术的成本效益在第2卷中讨论(布莱克等人,即将出版)。由于缺乏使用质量调整生命年(QALY)、伤残调整生命年(DALY)、挽救生命年(LYS)和避免死亡结果指标的研究,未涵盖牙科手术。本章涵盖的病症列于附件18A中,包括本卷其他章节中讨论的干预措施;第1章提供了所考虑的详细程序的更全面列表。这些是可在一级医院切实可行地进行的手术类型,尽管在二级医院也可进行,通常是在紧急病例到达这些急诊科室时。有些手术可在专门设施中进行,例如白内障医院、专门的移动设施、专注于特定外科病症的短期外科任务或创伤中心。我们简要总结了关于不同手术设施组织方式的成本效益的文献。在确定护理优先顺序时,公平性和可承受性是重要考虑因素。在讨论数据局限性并得出结论之前,我们将对这两个问题进行审查。本章使用世界卫生组织(WHO)的地理区域:非洲、美洲、东南亚、欧洲、东地中海和西太平洋。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验